<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/2259</identifier>
				<datestamp>2021-08-28T01:41:29Z</datestamp>
				<setSpec>bovine:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">The Value of re-treating the dry cow</dc:title>
	<dc:creator xml:lang="en">Studer, Erich</dc:creator>
	<dc:creator xml:lang="en">Hirose, Keiichi</dc:creator>
	<dc:creator xml:lang="en">Holtan, Arlin</dc:creator>
	<dc:creator xml:lang="en">McGinnis, Lynda</dc:creator>
	<dc:subject xml:lang="en">Antibiotics</dc:subject>
	<dc:subject xml:lang="en">Bovine mastitis</dc:subject>
	<dc:subject xml:lang="en">costs</dc:subject>
	<dc:subject xml:lang="en">Cows</dc:subject>
	<dc:subject xml:lang="en">Drug therapy</dc:subject>
	<dc:subject xml:lang="en">dry period</dc:subject>
	<dc:subject xml:lang="en">Mastitis</dc:subject>
	<dc:subject xml:lang="en">prevention</dc:subject>
	<dc:subject xml:lang="en">therapy</dc:subject>
	<dc:description xml:lang="en">Since the anti-mastitic effects of mammary gland infusion carried out at drying off last for approx. 20 days, whereas dry period tends to be approx. 60 days, a study was carried out to assess the economic and prophylactic value of re-treatment of cows during the dry period. Udders of Holstein cows that had been selected alternately from a herd of 420 were infused with Cephalosporin (200 mg/quarter) 2-3 wk prior to parturition. Incidence of mastitis at and after parturition was then assessed, and costs of re-treatment were compared with costs for treatment of mastitis outbreaks. For simple mastitis, cost of prophylactic retreatment was considerably higher than cost of treating one episode of mastitis; costs for treatment of severe mastitis were, however, approx. equivalent to costs of re-treatment. Routine prophylactic re-treatment is not therefore recommended for cows prepartum unless there is a high incidence of severe clinical mastitis post partum.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>1989-11-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/2259</dc:identifier>
	<dc:identifier>10.21423/bovine-vol0no24p114-116</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; No. 24 (1989 November); 114-116</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/2259/2251</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1989 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
